Decreased Consumption of Added Fructose Reduces Waist Circumference and Blood Glucose Concentration in Patients with Overweight and Obesity. The DISFRUTE Study: A Randomised Trial in Primary Care.

Santiago Domínguez-Coello, Lourdes Carrillo-Fernández, Jesús Gobierno-Hernández, Manuel Méndez-Abad, Carlos Borges-Álamo, José Antonio García-Dopico, Armando Aguirre-Jaime, Antonio Cabrera-de León

Journal: Nutrients 2021;12(4):1149

PMID: 32325919

Plain Language Summary

plain language summary logo

Cardiovascular disease, diabetes and obesity have increased in recent decades and some studies have established a direct link between insulin resistance (IR) and these conditions. Currently, the relationship between sugar intake and the risk of obesity and diabetes remains controversial. However, some studies involving overweight or obese participants without diabetes concluded that increasing fructose intake under certain conditions lead to the development of hepatic IR in adults. The primary objective of this randomised controlled study was to determine whether decreasing the consumption of foods with high amounts of fructose, independent of a reduction in calorie intake, led to a decrease in IR after 24 weeks. 438 adults who were obese or overweight but not diabetic, took part in the 24-week study, one group ate a low fructose diet and the other a standard diet. The low fructose diet did not reduce IR but it reduced waist circumference and fasting blood glucose. The authors conclude that in overweight and obese non-diabetic primary care patients, a small decrease in the consumption of added fructose in a sustained manner may be enough to achieve metabolic benefits. New studies with larger number of patients are needed.

Abstract

The relationship between fructose intake and insulin resistance remains controversial. Our purpose was to determine whether a reduction in dietary fructose is effective in decreasing insulin resistance (HOMA2-IR). This field trial was conducted on 438 adults with overweight and obese status, without diabetes. A total of 121 patients in a low fructose diet (LFD) group and 118 in a standard diet (SD) group completed the 24-week study. Both diets were prescribed with 30-40% of energy intake restriction. There were no between-group differences in HOMA2-IR. However, larger decreases were seen in the LFD group in waist circumference (-7.0 vs. -4.8 = -2.2 cms, 95% CI: -3.7, -0.7) and fasting blood glucose -0.25 vs. -0.11 = -0.14 mmol/L, 95% CI: -0.028, -0.02). The percentage of reduction in calorie intake was similar. Only were differences observed in the % energy intake for some nutrients: total fructose (-2 vs. -0.6 = -1.4, 95% CI: -2.6, -0.3), MUFA (-1.7 vs. -0.4 = -1.3, 95% CI: -2.4, -0.2), protein (5.1 vs. 3.6 = 1.4, 95% CI: 0.1, 2.7). The decrease in fructose consumption originated mainly from the reduction in added fructose (-2.8 vs. -1.9 = -0.9, 95% CI: -1.6, -0.03). These results were corroborated after multivariate adjustments. The low fructose diet did not reduce insulin resistance. However, it reduced waist circumference and fasting blood glucose concentration, which suggests a decrease in hepatic insulin resistance.

Address: Centro de Salud La Victoria de Acentejo-Tenerife, Calle Domingo Salazar 21, 38380 Tenerife, Canary Islands, Spain.; Unidad de Investigación de la Gerencia de Atención Primaria de Tenerife y del Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, 38310 Tenerife, Canary Islands, Spain.; Centro de Salud La Victoria de Acentejo, 38380 Tenerife, Canary Islands, Spain.; Centro de Salud de Güimar 38500Tenerife, Canary Islands, Spain.; Centro de Salud de la Orotava San Antonio, 38313 Tenerife, Canary Islands, Spain.; Centro de Salud Ruiz de Padrón, 38002 Tenerife, Canary Islands, Spain.; Laboratorio del Complejo Hospitalario Universitario de Canarias, 38320 La Laguna, Canary Islands, Spain.; Health Care Research Institute of the Santa Cruz de Tenerife College of Nursing, Colegio Oficial de Enfermeros de Santa Cruz de Tenerife, 38001 Tenerife, Spain.; European University of the Canary Islands-Member of Laureate International Universities, 38001 Tenerife, Canary Islands, Spain.; Unidad de Investigación de la Gerencia de Atención Primaria de Tenerife y del Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, 38010 Tenerife, Canary Islands, Spain.; Departamento de Medicina Preventiva y Salud Pública de la Universidad de la Laguna, 38200 La Laguna, Canary Island, Spain.

Patient Centred Factor

Laboratory Testing

Modifiable Lifestyle Factors

Jadad Score

Allocation Concealment

Nutrition Evidence Keywords

Bioactive Substances

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.